Sales & Marketing News | pharmaphorum

News

GSK's RSV shot cleared in US for all adults

GSK is back on level pegging with its rivals in the RSV vaccine category in the US, after getting FDA approval for Arexvy in the 18 to 49 age bracket.

News

Ipsen appoints Michelle Werner as North America head

Ipsen has appointed biopharma industry veteran Michelle Werner, who recently stepped down as CEO of Alltrna, to lead its North America division.

News

Eisai joins with Pokémon for sleep awareness drive

Eisai has launched a campaign to raise awareness of sleep disorders in Japan, via a partnership with smartphone app Pokémon Sleep.

News

Novo rapped by FDA for not reporting drug adverse effects

Novo Nordisk has been sent a warning letter from the FDA for violations of postmarketing adverse drug experience (PADE) regulations.

News

Veeva buys brand engagement firm Ostro for $100m

Veeva Systems has reached a $100m deal to acquire Ostro, which helps pharma connect with doctors and patients using AI-based conversational tools.

News

Multicoloured letters with AUTISM spelled in the middle

FDA approves leucovorin – but not for autism

The FDA stops short of approving leucovorin for autism, but will its clearance for ultra-rare condition CFD-FOLR1 lead to more off-label prescribing?

GSK's RSV shot cleared in US for all adults

Ipsen appoints Michelle Werner as North America head

Eisai joins with Pokémon for sleep awareness drive

Novo rapped by FDA for not reporting drug adverse effects

Veeva buys brand engagement firm Ostro for $100m

FDA approves leucovorin – but not for autism

FDA issues warning letters to five unapproved GLP-1 websites

Discover a new era of healthcare panel engagement: Grounded ...

News

Editor's Picks